|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01931 IVD MEDICAL
Nominal 
0.000 (0.000%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 5.235% | 4.838% | 4.219% | 4.082% | 11.201% |
| ROAE (%) | 7.330% | 6.849% | 5.988% | 5.599% | 14.600% |
| Return on Capital Employed (%) | 6.642% | 6.233% | 5.435% | 4.935% | 9.141% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 21.749% | 22.124% | 20.737% | 19.610% | 18.985% |
| EBITDA Margin (%) | 13.524% | 12.547% | 11.612% | 11.975% | 14.898% |
| Pre-tax Profit Margin (%) | 10.987% | 10.324% | 9.812% | 9.553% | 12.729% |
| Net Profit Margin (%) | 7.712% | 7.640% | 6.392% | 6.536% | 11.789% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 2.487 X | 2.618 X | 2.190 X | 3.045 X | 2.486 X |
| Quick Ratio (X) | 1.562 X | 1.953 X | 1.608 X | 2.298 X | 1.768 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 29.240% | 26.906% | 31.459% | 26.818% | 27.494% |
| Total Debt / Total Assets (%) | 7.196% | 8.111% | 9.792% | 10.796% | 7.068% |
| Net Debt / Total Assets (%) | -18.400% | -15.546% | -9.319% | -9.389% | -16.468% |
| Total Debt / Shareholders' Funds (%) | 10.294% | 11.097% | 14.356% | 14.794% | 9.704% |
| Long Term Debt / Shareholders' Funds (%) | 0.397% | 0.398% | 0.386% | 5.592% | 0% |
| Net Debt / Shareholders' Funds (%) | -26.322% | -21.269% | -13.662% | -12.866% | -22.611% |
| Net Cash / (Debt) ($) | 880.465M | 670.705M | 406.973M | 366.818M | 637.340M |
| Net Cash / (Debt) per share ($) | 0.650 | 0.495 | 0.301 | 0.277 | 0.478 |
| Total Debt / Capital Employed (%) | 9.602% | 10.386% | 13.316% | 13.115% | 9.093% |
| Interest Coverage Ratio (X) | 17.128 X | 10.280 X | 14.120 X | 10.769 X | 39.147 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 131.261 Day | 110.941 Day | 100.234 Day | 106.109 Day | 64.729 Day |
| Receivables Turnover (Day) | 64.940 Day | 74.354 Day | 65.828 Day | 61.801 Day | 43.246 Day |
| Payables Turnover (Day) | 49.083 Day | 54.223 Day | 49.325 Day | 43.935 Day | 29.388 Day |
| Remarks: | Real time quote last updated: 25/11/2024 07:43 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 125,288 |
| %Change | 21.628% |
| EPS / (LPS) | RMB 0.093 |
| NBV Per Share (¥) | RMB 2.505 |